Cellectar BioSciences Inc. buy Roth Mkm
Start price
04.03.24
/
50%
€3.68
Target price
04.03.25
€18.41
Performance (%)
-22.83%
Price
26.04.24
€2.84
Summary
This prediction is currently active. The prediction for Cellectar BioSciences Inc. disappoints with a performance of -22.83%. This prediction currently runs until 04.03.25. The prediction end date can be changed by Roth_Mkm at any time. Roth_Mkm has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Cellectar BioSciences Inc. | -1.389% | -1.389% |
| iShares Core DAX® | 2.594% | -1.158% |
| iShares Nasdaq 100 | 3.553% | -1.727% |
| iShares Nikkei 225® | 0.687% | -8.354% |
| iShares S&P 500 | 2.209% | -0.942% |
Comments by Roth_Mkm for this prediction
In the thread Cellectar BioSciences Inc. diskutieren
Cellectar Biosciences, Inc. (NASDAQ: CLRB) had its "buy" rating re-affirmed by analysts at Roth Mkm. They now have a $20.00 price target on the stock.
Ratings data for CLRB provided by MarketBeat
Stopped prediction by Roth_Mkm for Cellectar BioSciences Inc.
Cellectar BioSciences Inc.
Start price
Target price
Perf. (%)
€3.72
28.03.24
28.03.24
€25.93
28.03.25
28.03.25
-23.66%
26.04.24
26.04.24
